Development and evaluation of transdermal patches of celecoxib

PDA Journal of Pharmaceutical Science and Technology

Volumn 63, Issue 5, 2009, Pages 429-437

  Alam, Mohammad Intakhab ^a   Baboota, Sanjula ^a   Kohli, Kanchan ^a   Ali, Javed ^a   Ahuja, Alka ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Anti inflammatory study; Celecoxib; In vitro permeation; In vitro release; Transdermal patches

Indexed keywords

CARRAGEENAN; CELECOXIB; ETHYL CELLULOSE; OLEIC ACID; POVIDONE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG INHIBITION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOARTHRITIS; PAW EDEMA; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CYCLOOXYGENASE 2 INHIBITORS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; EXCIPIENTS; INFLAMMATION; OLEIC ACID; OSTEOARTHRITIS; PERMEABILITY; POVIDONE; PYRAZOLES; RATS; RATS, WISTAR; SKIN ABSORPTION; SULFONAMIDES; TIME FACTORS;

EID: 76049115297     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Arthritis Research Campaign. Arthritis: The Big Picture, http://www.arc.org.uk/about-arth/bigpic.htm (accessed May 17, 2004).
2. Kean, W. F.; Buchanan, W. W. The use of NSAIDs in rhumatic disorders: a global perspective. Inflammopharmacology 2005, 13 (4), 343-370.
3. Hawkey, C. J. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br. Med. J. 1990, 300 (6720), 278-284.
4. Griffin, M. R.; Scheiman, J. M. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am. J. Med. 2001, 110 (IA), 33S-37S.
5. Monkhouse, D. C; Huq, A. S. Transdermal drug delivery - problems and promises. Drug Dev. Ind. Pharm. 1988, 14 (2), 183-209.
6. Micromedex (R) Healthcare Series Vol. 125.
7. Reddy, M. N.; Rehana, T.; Ramakrishna, S.; Chowdary, K. P. R.; Diwan, P. V. β-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies. AAPS Pharm. Sci. 2004, 6 (1), Article 7, 1-9.
8. Paulson S. K.; Vaughn, M. B.; Jessen, S. M.; Lawal, Y.; Gresk, C. J.; Yan, B.; Maziasz, T. J.; Cook, C. S.; Karim, A. Pharmacokinetics of celecoxib after oral administration in dogs and humans. J. Pharmacol. Exp. Ther. 2001, 297 (2), 638-645.
9. Winter, C. A. Anti-Inflammatory Testing Methods: Comparative Evaluation of Indomethacin and Other Agents. In Garattini and Dukes International Symposium on Nonsteroidal Anti-Inflammatory Drugs; Excerpta Medica: Amsterdam, 1965, Vol. 82, pp 190-202.
10. Drug Stability: Principle and Practices, Carstensen, J. T., Ed.; Marcel Dekker Inc.: New York, 1990; Vol. 43.
11. Arora, P.; Mukherjee, B. Design, development, physicichemical, and in-vitro and in-vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 2002, 91 (9), 2076-2089.
12. Panchagnula, R.; Kandavilli, S.; Nair, V. Polymers in transdermal drug delivery systems. Pharm. Tech. 2002, 26 (5), 62-80.
13. Megrab, N. A.; Williams, A. C.; Barry, B. W. Estradiol permeation through human skin and silastic membrane - effects of propylene glycol and supersaturation. J. Controlled Release 1995, 36 (3), 277-294.
14. Rao, R. P.; Diwan, P. V. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm. 1998, 24 (4), 327-36.
15. nd ed.; Marcel Dekker Inc.: New York, 1987; Vol. 29, pp 140-159 and 524-549.
16. Chien, Y. W. Development of transdermal drug delivery systems. Drug Dev. Ind. Pharm. 1987,13 (4), 589-651.
17. Ranade, V. V. Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 1991, 31 (5), 401-418.
18. Fan, L. T.; Sing, S. K. Controlled Release: A Quantitative Treatment. Springer Verlag: New York, 1989; pp 13-56 and 85-29.
19. Andersson, T. L.; Stehle, B.; Davidsson, B.; Hoglund, P. Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Clinmara. Maturitas 2000, 34 (1), 57-64.
20. Bond, D. A.; Smith, P. A. Modeling the transport of low-molecular-weight penetrants within polymer matrix composites. Applied Mechanics Reviews 2006, 59 (5), 249-268.
21. Jiang, S. J.; Zhou, X. J. Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. Biol. Pharm. Bull. 2003, 26 (1), 66-68.